This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Alexander Schlemmer: Innovator in Myocardial Tissue Applications
Introduction
Alexander Schlemmer is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of biomedical engineering, particularly in the application of electric pulses to living myocardial tissue. His innovative work aims to enhance the treatment of cardiac conditions through advanced technology.
Latest Patents
Schlemmer holds a patent for an "Apparatus for applying electric pulses to living myocardial tissue." This apparatus is designed to apply at least one electric pulse to living myocardial tissue. It includes an input that receives an electric signal representing the current electric activity of the myocardial tissue. The signal processor processes this electric signal to calculate a present permutation value in the state space. It outputs a control signal only when the calculated present entropy value is lower than a predetermined threshold. The pulse generator then generates the electric pulse in response to this control signal, which is subsequently output to the myocardial tissue.
Career Highlights
Schlemmer is affiliated with the Max Planck Society for the Advancement of Science, where he continues to pursue his research and development efforts. His work is pivotal in advancing medical technologies that can potentially improve patient outcomes in cardiac care.
Collaborations
He collaborates with esteemed colleagues such as Ulrich Parlitz and Thomas Lilienkamp, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Alexander Schlemmer's contributions to the field of biomedical engineering, particularly through his patented apparatus for myocardial tissue applications, highlight his role as a key innovator in medical technology. His work continues to pave the way for advancements in cardiac treatment.